Our partners

Over the last few years, we have in-licensed a number of projects and opportunities from manufacturers and developers around the globe. Here is an overview of some of our current licenses and partnerships:

Company	Compound	Indication
Forest Laboratories, Inc.	Escitalopram	Depression
Teva Pharm. Industries Ltd.	Rasagiline	Parkinson's disease
Merz Pharmaceuticals	Memantine	Alzheimer's disease
PAION AG	Desmoteplase	Stroke
Solvay Pharmaceuticals B.V.	Bifeprunox	Schizophrenia
BioTie Therapies Corp.	Nalmefene	Alcohol dependence
Neurim Pharmaceuticals Ltd.	Circadin	Primary Insomnia
Takeda Pharmaceutical Company Ltd.	LU AA21004 LU AA24530	Mood and anxiety disorders

H. Lundbeck A/S
Ottiliavej 9
DK-2500 Copenhagen Valby

Tel +45 36 30 13 11
Fax +45 36 30 19 40

information@lundbeck.com

The specialist in psychiatry and pioneer in neurology
Disclaimer & Privacy statement